title: Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey.
abstract: BACKGROUND
  Data on the incidence of neuropathic pain (NeP) in Austria, its general characteristics and consequences for the quality of life (QOL) are still lacking. The prevalence in the United Kingdom is 8%.
  
  
  METHODS
  A representative survey (n=7707) was carried out. Patients with NeP were identified using previously validated criteria and subsequently asked to complete a questionnaire on QOL and detailed pain characteristics.
  
  
  RESULTS
  The prevalence of NeP was 3.3% (n=260). A higher prevalence was found in 41-50-year-olds (26%) and 51-60 year olds (24%). Pain was long lasting (>1 year: 66%; >5 years: 41%) and severe at onset (mean 6.8; numerical rating scale) as well as later (mean 4.7; 20% 8 or higher). Strong or predominant restriction of daily activities was reported in 65%, strong or predominant sleep disturbances in 60%, feelings of depression in 34% and anxiety in 25%.
  
  
  CONCLUSIONS
  For the first time, data on the prevalence of NeP in Austria are available. Pain patterns in those affected are characteristic and impact on QOL as well as pain intensity are severe.
authors.affiliation: Department of Anesthesiology and General Intensive Care Medicine, Medical University of Vienna, Vienna, Austria. burkhard.gustorff@meduniwien.ac.at
authors.forename: B
authors.initials: B
authors.lastname: Gustorff
authors.forename: T
authors.initials: T
authors.lastname: Dorner
authors.forename: R
authors.initials: R
authors.lastname: Likar
authors.forename: W
authors.initials: W
authors.lastname: Grisold
authors.forename: K
authors.initials: K
authors.lastname: Lawrence
authors.forename: F
authors.initials: F
authors.lastname: Schwarz
authors.forename: A
authors.initials: A
authors.lastname: Rieder
mesh_terms: D000041:Absenteeism; D000203:Activities of Daily Living; D000328:Adult; D000368:Aged; D000700:Analgesics / Q000627:therapeutic use; D001317:Austria / Q000453:epidemiology; D002908:Chronic Disease; D003131:Combined Modality Therapy; D003863:Depression; D005239:Fear; D005260:Female; D006306:Health Surveys; D006801:Humans; D008297:Male; D008875:Middle Aged; D009437:Neuralgia / Q000150:complications / Q000453:epidemiology* / Q000523:psychology / Q000628:therapy; D010342:Patient Acceptance of Health Care / Q000706:statistics & numerical data; D026741:Physical Therapy Modalities / Q000706:statistics & numerical data; D015995:Prevalence; D011446:Prospective Studies; D011788:Quality of Life; D020919:Sleep Disorders, Intrinsic / Q000453:epidemiology / Q000209:etiology
chemical_list: D000700:Analgesics